Drug intelligence / Profile preview

Danduqing Granules

Development stage
Unknown
Lead developer
Qingdao Haichuan Center for Innovative Biomedical Research
Modality
Small Molecules
Administration
Oral
01

Overview

Danduqing Granules is a Traditional Chinese Medicine (TCM) candidate developed by the Qingdao Haichuan Innovative Natural Medicine Research Center for the treatment of erysipelas, specifically targeting the damp-heat and toxin syndrome. Erysipelas is an acute bacterial infection of the dermis and superficial lymphatics, typically caused by *Streptococcus pyogenes*, which presents as well-demarcated, erythematous, and edematous skin lesions. The formulation is designed to clear heat, resolve toxins, and cool the blood, addressing the underlying TCM etiology of fire-toxin accumulation. Clinical development in China has evaluated the efficacy of Danduqing Granules in reducing both local symptoms, such as skin redness and pain, and systemic symptoms like fever, potentially serving as an alternative or adjunct to conventional antibiotic therapy.

Brand names
Danduqing Granules
Other names
Danduqing Keli丹毒清颗粒

Beyond the preview

Go deeper on Danduqing Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Danduqing Granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call